Deutsch English Français

Contact

EP0782440

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0782440

EP0782440 - INJECTION-MOLDED DOSAGE FORM [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 31.05.2002 Database last updated on 04.11.2024
Most recent event Tooltip	04.01.2008	Lapse of the patent in a contracting state New state(s): CH, IT, LI	published on 06.02.2008 [2008/06]
Applicant(s)	For all designated states ALZA Corporation 1900 Charleston Avenue P.O. Box 7210 Mountain View, CA 94039-7210 / US
	[N/P]
Former [2001/45]	For all designated states ALZA CORPORATION 1900 Charleston Avenue, P.O. Box 7210 Mountain View, CA 94039-7210 / US
Former [1997/28]	For all designated states ALZA CORPORATION 950 Page Mill Road P.O. Box 10950 Palo Alto California 94303-0802 / US
Inventor(s)	01 / DONG, Liang C. 457 Sierra Vista, Unit 5 Mountain View, CA 94043 / US
	02 / WONG, Patrick S.-L. 2030 Cornell Street Palo Alto, CA 94306 / US
	03 / POLLOCK, Crystal 120 Granada Drive, No. 15 Mountain View, CA 94043 / US
	04 / FERRARI, Vincent Joseph 360 E. Evelyn Avenue Sunnyvale, CA 94086 / US
	[1997/28]
Representative(s)	Stebbing, Peter John Hunter, et al Ablett & Stebbing, Caparo House, 101-103 Baker Street London W1M 1FD / GB
	[N/P]
Former [1997/28]	Stebbing, Peter John Hunter, et al Ablett & Stebbing 45 Lancaster Mews Lancaster Gate London W2 3QQ / GB
Application number, filing date	95937597.3	20.10.1995
	[1997/28]
	WO1995US13619
Priority number, date	US19940330892	28.10.1994 Original published format: US 330892
	[1997/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9613248
	Date:	09.05.1996
	Language:	EN
	[1996/21]
	Type:	A1 Application with search report
	No.:	EP0782440
	Date:	09.07.1997
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.05.1996 takes the place of the publication of the European patent application.
	[1997/28]
	Type:	B1 Patent specification
	No.:	EP0782440
	Date:	25.07.2001
	Language:	EN
	[2001/30]
Search report(s)	International search report - published on:	EP	09.05.1996
Classification	IPC:	A61K9/00	[1997/28]
	CPC:	C08L67/04 (EP,US); A61K9/00 (KR); A61K47/34 (EP,US); A61K47/38 (EP,US); A61K9/0004 (EP,US); A61K9/2095 (EP,US); (+) B01D71/48 (EP,KR,US); C08L71/02 (EP,US); C08L1/284 (EP,US) (-)
	C-Set:	C08L67/04, C08L2666/02 (US,EP); C08L67/04, C08L2666/26 (EP,US); C08L67/04, C08L71/00 (US,EP); C08L71/02, C08L2666/18 (US,EP)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/28]
Title	German:	SPRITZGEGOSSENE DARREICHUNGSFORM	[1997/28]
	English:	INJECTION-MOLDED DOSAGE FORM	[1997/28]
	French:	FORME GALENIQUE MOULEE PAR INJECTION	[1997/28]
Entry into regional phase	26.02.1997	National basic fee paid
	26.02.1997	Designation fee(s) paid
	26.02.1997	Examination fee paid
Examination procedure	28.05.1996	Request for preliminary examination filed International Preliminary Examining Authority: EP
	26.02.1997	Examination requested [1997/28]
	05.10.1999	Despatch of a communication from the examining division (Time limit: M04)
	28.01.2000	Reply to a communication from the examining division
	17.05.2000	Despatch of a communication from the examining division (Time limit: M04)
	16.06.2000	Reply to a communication from the examining division
	27.09.2000	Despatch of communication of intention to grant (Approval: Yes)
	29.01.2001	Communication of intention to grant the patent
	24.04.2001	Fee for grant paid
	24.04.2001	Fee for publishing/printing paid
Divisional application(s)	EP00201378.7 / EP1057478
Opposition(s)	26.04.2002	No opposition filed within time limit [2002/29]
Fees paid	Renewal fee
	26.09.1997	Renewal fee patent year 03
	05.10.1998	Renewal fee patent year 04
	04.10.1999	Renewal fee patent year 05
	04.10.2000	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	25.07.2001
	BE	25.07.2001
	CH	25.07.2001
	IT	25.07.2001
	LI	25.07.2001
	NL	25.07.2001
	LU	20.10.2001
	IE	22.10.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
	GR	26.10.2001
	ES	31.01.2002
	[2008/06]
Former [2004/51]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	LU	20.10.2001
	IE	22.10.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
	GR	26.10.2001
	ES	31.01.2002
Former [2004/42]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	LU	20.10.2001
	IE	22.10.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
	ES	31.01.2002
Former [2004/39]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	LU	20.10.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
	ES	31.01.2002
Former [2004/04]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
	ES	31.01.2002
Former [2003/45]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	DK	25.10.2001
	PT	25.10.2001
	SE	25.10.2001
Former [2003/09]	AT	25.07.2001
	BE	25.07.2001
	NL	25.07.2001
	PT	25.10.2001
	SE	25.10.2001
	FR	21.12.2001
Former [2002/29]	AT	25.07.2001
	BE	25.07.2001
	PT	25.10.2001
	SE	25.10.2001
	FR	21.12.2001
Former [2002/26]	AT	25.07.2001
	PT	25.10.2001
	SE	25.10.2001
	FR	21.12.2001
Former [2002/18]	AT	25.07.2001
	SE	25.10.2001
	FR	21.12.2001
Former [2002/15]	AT	25.07.2001
	SE	25.10.2001
Former [2002/05]	SE	25.10.2001
Cited in	International search	[X]US4855141 (ECKENHOFF JAMES B [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p